Anemia in conventional hemodialysis: Finding the optimal treatment balance-Reference-Cited by-同舟云学术

Anemia in conventional hemodialysis: Finding the optimal treatment balance

Published:2018-06-17 Issue:6 Volume:31 Page:599-606
ISSN:0894-0959
Container-title:Seminars in Dialysis
language:en
Short-container-title:Semin Dial

Author:

Hasegawa Takeshi¹²³⁴,Koiwa Fumihiko²,Akizawa Tadao⁵

Affiliation:

1. Office for Promoting Medical Research; Showa University; Tokyo Japan

2. Division of Nephrology; Department of Medicine; Showa University Fujigaoka Hospital; Yokohama Japan

3. Center for Innovative Research for Communities and Clinical Excellence; Fukushima Medical University; Fukushima Japan

4. Department of Healthcare Epidemiology; School of Public Health in the Graduate School of Medicine; Kyoto University; Kyoto Japan

5. Division of Nephrology; Department of Medicine; Showa University School of Medicine; Tokyo Japan

Publisher

Wiley

Subject

Nephrology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/sdi.12719/fullpdf

Reference66 articles.

1. Pathogenesis of renal anemia;Nangaku;Semin Nephrol,2006

2. Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988-1994);Astor;Arch Int Med,2002

3. Anemia: An early complication of chronic renal insufficiency;Kazmi;Am J Kidney Dis,2001

4. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative;NKF-DOQI;Am J Kidney Dis,1997

5. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000;NKF-K/DOQI;Am J Kidney Dis,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relation between erythropoietin resistance and metabolic syndrome in hemodialysis patients: A multicentric propensity score matched analysis;Journal of Investigative Medicine;2023-05-18

2. Market Consolidation and Innovation in US Dialysis;Advances in Chronic Kidney Disease;2022-01

3. JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat;European Journal of Pharmacology;2021-05

4. Anemia management for home dialysis including the new US public policy initiative;Kidney International Supplements;2021-04

5. Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus;Kidney and Blood Pressure Research;2021